New drug aims to keep schizophrenia in check
NCT ID NCT07686263
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether KarXT (a combination of xanomeline and trospium chloride) can prevent relapse in people with schizophrenia. Participants who have had a recent hospitalization for schizophrenia and still have symptoms will receive KarXT or a placebo. The study measures how long it takes for a relapse to occur and tracks side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Xanomeline/Trospium Chloride (KarXT)
- What this could lead to
- If successful, this could provide a new treatment option to help people with schizophrenia maintain stability and avoid relapse.
- What could go wrong
- This is an early-phase trial, and results may not confirm effectiveness. Side effects related to cholinergic activity are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Local Institution - 0001
Poznan, 60-744, Poland
Contact
-
Local Institution - 0002
Córdoba, 5000, Argentina
Contact
-
Local Institution - 0014
Klecany, 25067, Czechia
Contact
-
Local Institution - 0021
Little Rock, Arkansas, 72211, United States
Contact
-
Local Institution - 0023
St Louis, Missouri, 63141, United States
-
Local Institution - 0030
Pico Rivera, California, 90660, United States
Contact
-
Local Institution - 0032
Culver City, California, 90230, United States
Contact
-
Local Institution - 0037
Garden Grove, California, 92845, United States
Contact
-
Local Institution - 0040
Bellflower, California, 90706, United States
Contact
-
Local Institution - 0044
West Palm Beach, Florida, 33407, United States
Contact
-
Local Institution - 0047
Oklahoma City, Oklahoma, 73112, United States
Contact
-
Local Institution - 0049
Austin, Texas, 78754, United States
Contact
-
Local Institution - 0054
Miami Lakes, Florida, 33016, United States
-
Local Institution - 0055
Iași, 700282, Romania
Contact
-
Local Institution - 0056
Chicago, Illinois, 60641, United States
Contact
-
Local Institution - 0067
Chicago, Illinois, 60640-5017, United States
Contact
-
Local Institution - 0068
La Habra, California, 90631, United States
Contact
-
Local Institution - 0070
Sandy Springs, Georgia, 30328, United States
Contact
-
Local Institution - 0075
Miami, Florida, 33135, United States
-
Local Institution - 0101
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Local Institution - 0103
Bucharest, Bucharest, 041914, Romania
Contact
-
Local Institution - 0105
Bucharest, Bucharest, 041914, Romania
Contact
-
Local Institution - 0106
Bucharest, 41914, Romania
Contact
-
Local Institution - 0107
Bucharest, Bucharest, 041914, Romania
Contact
-
Local Institution - 0109
Bucharest, 41914, Romania
Contact
-
Local Institution - 0110
Bucharest, Bucharest, 041914, Romania
Contact
-
Local Institution - 0112
Barcelona, Barcelona [Barcelona], 08003, Spain
Contact
-
Local Institution - 0120
Gdansk, Pomeranian Voivodeship, 80-214, Poland
Contact
-
Local Institution - 0122
Bialystok, Podlaskie Voivodeship, 15-272, Poland
Contact
-
Local Institution - 0123
Warsaw, Masovian Voivodeship, 02-957, Poland
Contact
-
Local Institution - 0128
Lemon Grove, California, 91945, United States
Contact
-
Local Institution - 0133
Bentonville, Arkansas, 72712, United States
Contact
-
Local Institution - 0134
Miami Springs, Florida, 33166, United States
-
Local Institution - 0135
Buffalo, New York, 14215, United States
-
Local Institution - 0139
Little Rock, Arkansas, 72204, United States
Contact
-
Local Institution - 0143
Buenos Aires, C1199ABB, Argentina
Contact
-
Local Institution - 0144
Santiago del Estero, 4200, Argentina
Contact
-
Local Institution - 0145
Hollywood, Florida, 33024, United States
Contact
-
Local Institution - 0149
Hollywood, Florida, 33021, United States
-
Local Institution - 0151
Orange, California, 92868, United States
Contact
-
Local Institution - 0153
Rogers, Arkansas, 72758, United States
Contact
-
Local Institution - 0154
Bentonville, Arkansas, 72712, United States
Contact
-
Local Institution - 0157
Glostrup, Region Sjælland, 2600, Denmark
Contact
-
Local Institution - 0158
Aalborg, 9000, Denmark
Contact
-
Local Institution - 0159
Aarhus, Central Jutland, 8200, Denmark
Contact
-
Local Institution - 0162
Brno, 625 00, Czechia
Contact
-
Local Institution - 0166
Atlanta, Georgia, 30331, United States
Contact
-
Local Institution - 0167
Valladolid, 47012, Spain
Contact
-
Local Institution - 0174
Bucharest, 011241, Romania
Contact
-
Local Institution - 0175
Río Cuarto, Córdoba Province, 5800, Argentina
Contact
-
Local Institution - 0177
Oxford, Oxfordshire, OX3 7JX, United Kingdom
Contact
-
Local Institution - 0181
Zamora, 49021, Spain
Contact
-
Local Institution - 0182
Hovedvejen 19, Frederiksberg, 2000, Denmark
Contact
-
Local Institution - 0183
Cincinnati, Ohio, 45219, United States
Contact
-
Local Institution - 0185
Redlands, California, 92373, United States
Contact
-
Local Institution - 0186
Riverside, California, 92506, United States
Contact
-
Local Institution - 0187
Montclair, California, 91763, United States
Contact
-
Local Institution - 0188
Chino, California, 91710, United States
Contact
-
Local Institution - 0189
Savannah, Georgia, 31405, United States
Contact
-
Local Institution - 0190
Anaheim, California, 92805, United States
Contact
-
Local Institution - 0191
Novi Iskar, 1282, Bulgaria
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a video call strengthen families facing schizophrenia?
- Virtual family therapy may tame schizophrenia symptoms — a trial investigates
- Could a Once-Every-Few-Weeks shot replace daily pills for schizophrenia?
- Can a tailored self-management program improve health outcomes for those with serious mental illness?
- PET scans reveal how antipsychotics target key brain receptors in schizophrenia
- Immune clues in schizophrenia: could inflammation subtypes guide treatment?